Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension.

Wallbach M, Zürbig P, Dihazi H, Müller GA, Wachter R, Beige J, Koziolek MJ, Mischak H.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1519-1526. doi: 10.1111/jch.13365. Epub 2018 Sep 10.

2.

Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.

Tofte N, Lindhardt M, Adamova K, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Kooy A, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Ruggenenti PL, Rutters F, Rychlík I, Spasovski G, Speeckaert M, Trillini M, von der Leyen H, Rossing P.

Diabet Med. 2018 Oct;35(10):1375-1382. doi: 10.1111/dme.13669. Epub 2018 Jun 6.

PMID:
29781558
3.

The Pituitary-Thyroid Axis and Prolactin Secretion in Hemodialysis Patients in Two Endemic Regions of Eastern Germany.

Rasche FM, Rettig R, Frese T, Rasche WG, Barinka F, Roesl G, Keller F, Lindner TH, Schneider JG, Beige J, Ebert T, Schiekofer S.

Exp Clin Endocrinol Diabetes. 2018 Jun;126(6):349-356. doi: 10.1055/s-0043-123184. Epub 2018 Feb 23.

PMID:
29475205
4.

Endemic influences of political regimes, healthcare systems, and preferences on the frequencies and incidences of nephropathies in eastern Saxony, Germany
.

Sedaghat S, Heshmati ES, Frese T, Rasche WG, Barinka F, Fahr F, Beige J, Schiekofer S, Rasche FM.

Clin Nephrol. 2017 Dec;88(12):317-327. doi: 10.5414/CN109229.

PMID:
29115212
5.

[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].

Koziolek M, Beige J, Wallbach M, Zenker D, Henning G, Halbach M, Mader N, Mahfoud F, Schlieper G, Schwenger V, Hausberg M, Börgel J, Lodde M, van der Giet M, Müller-Ehmsen J, Passauer J, Parmentier S, Lüders S, Krämer BK, Büttner S, Limbourg F, Jordan J, Vonend O, Predel HG, Reuter H.

Internist (Berl). 2017 Oct;58(10):1114-1123. doi: 10.1007/s00108-017-0308-y. Review. German.

PMID:
28835975
6.

Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy.

Abdel-Hady Algharably E, Beige J, Kreutz R, Bolbrinker J.

Pharmacogenomics J. 2018 Apr;18(2):227-231. doi: 10.1038/tpj.2017.14. Epub 2017 Apr 18.

PMID:
28418009
7.

FSTL3 is increased in renal dysfunction.

Kralisch S, Hoffmann A, Klöting N, Bachmann A, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Blüher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1637-1644. doi: 10.1093/ndt/gfw472.

PMID:
28339962
8.

Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy.

Beige J, Jentzsch T, Wendt R, Hennig G, Koziolek M, Wallbach M.

J Hypertens. 2017 Jul;35(7):1496-1501. doi: 10.1097/HJH.0000000000001339.

PMID:
28267039
9.

An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.

Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim MK, Lovett EG, Schafer JE, de Leeuw PW.

J Am Soc Hypertens. 2017 Feb;11(2):81-91. doi: 10.1016/j.jash.2016.12.003. Epub 2016 Dec 16.

10.

Limited Accuracy of Colour Doppler Ultrasound Dynamic Tissue Perfusion Measurement in Diabetic Adults.

Stoperka F, Karger C, Beige J.

PLoS One. 2016 Dec 29;11(12):e0168905. doi: 10.1371/journal.pone.0168905. eCollection 2016.

11.

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.

Siwy J, Zürbig P, Argiles A, Beige J, Haubitz M, Jankowski J, Julian BA, Linde PG, Marx D, Mischak H, Mullen W, Novak J, Ortiz A, Persson F, Pontillo C, Rossing P, Rupprecht H, Schanstra JP, Vlahou A, Vanholder R.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2079-2089. doi: 10.1093/ndt/gfw337.

12.

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.

Lindhardt M, Persson F, Currie G, Pontillo C, Beige J, Delles C, von der Leyen H, Mischak H, Navis G, Noutsou M, Ortiz A, Ruggenenti PL, Rychlik I, Spasovski G, Rossing P.

BMJ Open. 2016 Mar 2;6(3):e010310. doi: 10.1136/bmjopen-2015-010310.

13.

Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.

Heusser K, Tank J, Brinkmann J, Menne J, Kaufeld J, Linnenweber-Held S, Beige J, Wilhelmi M, Diedrich A, Haller H, Jordan J.

Hypertension. 2016 Mar;67(3):585-91. doi: 10.1161/HYPERTENSIONAHA.115.06486. Epub 2016 Feb 1.

14.

Reconstructive kidney surgery for organ-preserving therapy of renal tumors.

Hamza A, Günther M, Behrendt W, Tietze S, Beige J.

GMS Interdiscip Plast Reconstr Surg DGPW. 2015 Nov 16;4:Doc10. doi: 10.3205/iprs000069. eCollection 2015.

15.

Baroreflex activation therapy in patients with end-stage renal failure: proof of concept.

Beige J, Koziolek MJ, Hennig G, Hamza A, Wendt R, Müller GA, Wallbach M.

J Hypertens. 2015 Nov;33(11):2344-9. doi: 10.1097/HJH.0000000000000697.

PMID:
26335429
16.

CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN.

Brix SR, Stege G, Disteldorf E, Hoxha E, Krebs C, Krohn S, Otto B, Klätschke K, Herden E, Heymann F, Lira SA, Tacke F, Wolf G, Busch M, Jabs WJ, Özcan F, Keller F, Beige J, Wagner K, Helmchen U, Noriega M, Wiech T, Panzer U, Stahl RA.

J Am Soc Nephrol. 2015 Sep;26(9):2105-17. doi: 10.1681/ASN.2014040407. Epub 2015 Mar 11.

17.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R.

J Am Soc Nephrol. 2015 Aug;26(8):1999-2010. doi: 10.1681/ASN.2014050423. Epub 2015 Jan 14.

18.

Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction.

Ebert T, Hopf LM, Wurst U, Bachmann A, Kralisch S, Lössner U, Platz M, Kratzsch J, Stolzenburg JU, Dietel A, Grisk O, Beige J, Anders M, Bast I, Klöting N, Blüher M, Stumvoll M, Fasshauer M.

Nutr Metab Cardiovasc Dis. 2014 Sep;24(9):1027-34. doi: 10.1016/j.numecd.2014.03.006. Epub 2014 Apr 2.

PMID:
24813306
19.

Limited acute influences of electrical baroreceptor activation on insulin sensitivity and glucose delivery: a randomized, double-blind, crossover clinical study.

May M, Ahrens J, Menne J, Haller H, Beige J, Eckert S, Jordan J, Engeli S.

Diabetes. 2014 Aug;63(8):2833-7. doi: 10.2337/db13-1651. Epub 2014 Mar 19.

20.

Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction.

Hindricks J, Ebert T, Bachmann A, Kralisch S, Lössner U, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Blüher M, Stumvoll M, Fasshauer M.

Clin Endocrinol (Oxf). 2014 Jun;80(6):918-24. doi: 10.1111/cen.12380. Epub 2014 Jan 12.

PMID:
24612017

Supplemental Content

Loading ...
Support Center